Monies from Hong Kong investors fuel innovation, new product development, and increased access to CBD for patients
Monies from Hong Kong investors fuel innovation, new product development, and increased access to CBD for patients
GOLDEN, Colo., March 14, 2019 /PRNewswire/ -- C-BeyondHealth, LLC, a leading healthcare product development company specializing in medicinal cannabinoid products, is pleased to announce an investment from Triple Ten, a multi-national holding company based in Hong Kong. The company is one of the few U.S. medicinal cannabinoid enterprises to receive considerable funding from Asia. The significant investment from Triple Ten signifies the start of precedent-setting expansion into Thailand once current government regulations are lifted.
“We started this company with a global scope believing our cannabis-based products would impact how patients and healthcare practitioners around the world address various health problems,” said Scott Reese, CEO of C-BeyondHealth, LLC. “With significant funding from Triple Ten, we will open the market for innovative cannabinoid-based product lines and build new relationships with the highest levels of government in these markets.”
“We are thrilled to announce our investment in C-BeyondHealth, LLC,” said Thongchai Kolsrichai, Managing Partner of Triple Ten Company Limited. “Partnering with one of the leading cannabinoid-based product development companies in the United States means we now have a vested interest in a company that is setting new quality and efficacy standards in the medicinal cannabis industry. The alliance between our two companies is strong, and we believe emerging markets like Thailand will play a large role in the global expansion of the company.”
The funds from Hong Kong investors will help the company grow more quickly to meet the enormous demand for reliable and practical cannabis-based solutions, support ongoing product innovation, and will fund the development of new markets.
About C-BeyondHealth, LLC
C-BeyondHealth, LLC is a patient-directed product development company dedicated to advancing the science and availability of targeted cannabinoid formulations. C-BeyondHealth, LLC is headquartered in Golden, Colorado with registered business operations in Bangkok, Thailand. For more information visit c-beyondhealth.com, or for press inquiries, please email press@c-beyondhealth.com.
About Triple Ten Company Limited
Triple Ten Company Limited is a multi-national holding company based in Hong Kong that has an interest in medicinal cannabis and cannabinoid business in Asia, especially Thailand. In addition to healthcare, Triple Ten Company Ltd. has interests in agricultural development, media holdings, real estate, and resort operations.
Contact: Pamela M. Green
Phone: 877-277-CBYD x2
Email: press@c-beyondhealth.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/investment-from-hong-kong-based-holding-company-fuels-innovation-and-global-expansion-for-c-beyondhealth-llc-300812864.html
SOURCE C-Beyond Health, LLC
